Tag: gut health

The landscape of modern endocrinology is undergoing a significant transformation, moving beyond the traditional focus on hormonal metrics toward a more integrated, human-centric approach to leadership and patient care. This shift was a central theme at the recent Excellence in Clinical Endocrinology Leadership (EXCEL) meeting, hosted by the Endocrine Society at its headquarters in Washington,…

The Endocrine Society has officially released its annual Early-Career issue of Endocrine News, a publication dedicated to highlighting the contributions of emerging researchers and clinicians who are redefining the landscape of endocrinology. The July edition serves as a critical platform for showcasing the intersection of legacy mentorship, groundbreaking metabolic discoveries, and the evolving philosophy of…

On July 15, a landmark coalition of 38 professional medical organizations, patient advocacy groups, and research institutions gathered in Washington, D.C., to unveil the National Strategy to Close the Women’s Health Gap. This ambitious framework, led by the Society for Women’s Health Research (SWHR), the American College of Obstetricians and Gynecologists (ACOG), and the Women…

The Endocrine Society has officially released its latest treatment recommendations, titled Central Precocious Puberty: An Endocrine Society Clinical Practice Guideline, during the high-profile ENDO 2026 conference held in Chicago. This highly anticipated session drew a massive audience of pediatricians, endocrinologists, and researchers, all eager to understand the shifting landscape of childhood development. The new guidelines…

The Endocrine Society has officially announced the appointment of Nanette Santoro, MD, as its president for the 2026–2027 term. Dr. Santoro, a distinguished figure in reproductive endocrinology and the E. Stewart Taylor Chair of Obstetrics & Gynecology at the University of Colorado School of Medicine, is slated to succeed Carol Lange, PhD, in June 2026.…

A significant proportion of patients prescribed glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes follow a "start-and-stop" pattern of usage rather than consistent, long-term adherence, according to a comprehensive study presented at ENDO 2026. The research, which analyzed the treatment trajectories of more than 60,000 Americans, reveals that while discontinuation rates are higher than…

The ENDO 2026 annual meeting served as a pivotal platform for the global endocrinology community, unveiling a series of clinical breakthroughs that promise to reshape the treatment landscape for rare and chronic endocrine disorders. From the introduction of novel oral therapies for Congenital Adrenal Hyperplasia (CAH) to long-term data confirming the efficacy of oral treatments…

The Endocrine Society’s annual meeting, ENDO 2026, convened in Chicago, Illinois, serving as the premier global forum for the latest advancements in endocrine research and clinical practice. Bringing together thousands of clinicians, researchers, and students from across the globe, the conference highlighted the evolving landscape of hormone-related health, ranging from pediatric developmental milestones to the…

The landscape of modern endocrinology is undergoing a profound transformation, marked by a shift from purely clinical management to a more holistic, advocacy-driven approach that integrates metabolic health, oncological support, and systemic nomenclature changes. Recent developments within the field, highlighted by the Endocrine Society and leading academic journals such as The Lancet, underscore the evolving…

In a significant month for the pharmaceutical industry and metabolic medicine, the U.S. Food and Drug Administration (FDA) has issued two landmark approvals that promise to reshape the treatment paradigms for pediatric type 1 diabetes and severe hypertriglyceridemia. On June 13, Sanofi received accelerated approval for Tzield (teplizumab-mzwv) to delay the decline of insulin production…